Neoplasm Breast

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-18
Clinical Trial Update: Assessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer [Phase 4]
Phase 4 clinical trial evaluating immunogenicity response after eribulin treatment in advanced/metastatic breast cancer.